Perrigo Company plc Stock News

Related Stocks: ADI , AON , KIM , MRNA , MTCH , TECH , BRO , CDAY , BBWI , MXIM , ALXN , NOV , UNM , PRGO ,

Related Stocks: ADI , DVN , MRNA , MTCH , BBWI , CDAY , TECH , BRO , ALXN , MXIM , PRGO , UNM ,

Related Stocks: ADI , KIM , UA , MRNA , MTCH , TECH , BBWI , CDAY , BRO , ALXN , MXIM , NOV , PRGO , UNM ,

Complete study of the global Loratadine Syrup market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the

The global Tinea Corporis Treatment market size is projected a CAGR of 3.6% during 2021-2027. Fungus contaminations are contagious diseases brought about by Tinea rubrum, Trichophyton mentagrophytes and Epidermophyton floccosum. This dermatophyte parasite flourishes in damp conditions. Fungus corporis, known

Related Stocks: ADI , KIM , MRNA , MTCH , TECH , CDAY , BRO , ALXN , MXIM , PRGO , UNM , NOV ,

Related Stocks: SGMS , KNX , RUN , PGNY , MLKN , GME , GXO , TNDM , PFGC , PRGO , SAIA , TECH , CDAY , BRO , THS , HCSG , CNK ,

Related Stocks: PRGO ,

Stocks Analysis by Zacks Investment Research covering: State Street Corp, Perrigo Company PLC. Read Zacks Investment Research''s latest article on Investing.com

Teva, ICL and Perrigo led the rises today but NICE Systems slipped.

Related Stocks: PRGO ,

Perrigo (NYSE:PRGO) issued an update on its FY 2021 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $2.000-$2.100 for the period, compared to the Thomson Reuters consensus estimate of $2.460. The company issued revenue guidance of -. NYSE:PRGO traded down $0.04 during trading hours on Friday, hitting $35.79. 1,269,846 []

Shares of Perrigo Company plc (NYSE:PRGO) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $35.38 and last traded at $35.79, with a volume of 16387 shares changing hands. The stock had previously closed at $35.85. PRGO has been the topic of a number of recent research []

List of the Companies Operating in the Market: GlaxoSmithKline plc (U.K, Europe), Johnson & Johnson Inc (New Jersey, U.S), Perrigo Company plc (Ireland, Europe), Pierre Fabre SA, Laboratories (France, Europe), Pfizer Inc. (New York, United States), Cipla Limited (Mumbai, India), British American Tobacco Plc (U.K, Europe), Other Players List of the Companies Operating in the Market: GlaxoSmithKline plc (U.K, Europe), Johnson & Johnson Inc (New Jersey, U.S), Perrigo Company plc (Ireland, Europe), Pierre Fabre SA, Laboratories (France, Europe), Pfizer Inc. (New York, United States), Cipla Limited (Mumbai, India), British American Tobacco Plc (U.K, Europe), Other Players

Perrigo Company plc (PRGO) shares closed 0.1% lower than its previous 52 week low, giving the company a market cap of $5B. The stock is currently down 14.8% year-to-date, down 20.6% over the past 12 months, and down 53.2% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%. Trading Activity Trading volume this week was 12.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1447.6% The company's stock price performance over the past 12 months lags the peer average by -349.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.